Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DORIS HANSEN

Allopathic & Osteopathic Physicians Internal Medicine Hematology

NPI
1881958270
CMS profile
587817
Location
TAMPA, FL

General Payments · PY2018–2024

$110,118.97

  • Reported across 127 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$79,724.53

34 records · 1 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Scientific Affairs, LLC $51,800.00 2
E.R. Squibb & Sons, L.L.C. $15,766.42 7
Janssen Biotech, Inc. $7,107.84 11
Legend Biotech USA Inc. $4,489.71 7
Celgene Corporation $355.54 3
SANOFI-AVENTIS U.S. LLC $68.21 1
AstraZeneca UK Limited $60.00 1
PFIZER INC. $50.52 1
ABBVIE INC. $26.29 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,050.77 56
PY2019 $468.88 9
PY2022 $9,976.92 9
PY2023 $18,897.87 19
PY2024 $79,724.53 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018201920222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $26.29 08/30/2024 Food and Beverage Undisputed 01/23/2026 1103875880 CMS
AstraZeneca UK Limited $60.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 1093887292 CMS
Celgene Corporation $300.00 06/04/2024 Consulting Fee Undisputed 01/23/2026 1101146113 CMS
Celgene Corporation $27.77 12/06/2024 Food and Beverage Undisputed 01/23/2026 1101146115 CMS
Celgene Corporation $27.77 12/06/2024 Food and Beverage Undisputed 01/23/2026 1101146117 CMS
E.R. Squibb & Sons, L.L.C. $36.67 02/23/2024 Food and Beverage Undisputed 01/23/2026 1101489119 CMS
E.R. Squibb & Sons, L.L.C. $6,987.00 04/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1101489123 CMS
E.R. Squibb & Sons, L.L.C. $1,056.75 05/16/2024 Travel and Lodging Undisputed 01/23/2026 1101489159 CMS
E.R. Squibb & Sons, L.L.C. $125.00 05/16/2024 Food and Beverage Undisputed 01/23/2026 1101489165 CMS
E.R. Squibb & Sons, L.L.C. $1,038.00 05/23/2024 Consulting Fee Undisputed 01/23/2026 1101489144 CMS
E.R. Squibb & Sons, L.L.C. $2,076.00 06/04/2024 Consulting Fee Undisputed 01/23/2026 1101489148 CMS
E.R. Squibb & Sons, L.L.C. $4,447.00 06/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1101489156 CMS
Janssen Biotech, Inc. $1,362.50 03/22/2024 Consulting Fee Undisputed 01/23/2026 1078492991 CMS
Janssen Biotech, Inc. $128.35 06/25/2024 Food and Beverage Undisputed 01/23/2026 1078493660 CMS
Janssen Biotech, Inc. $5,046.00 08/08/2024 Travel and Lodging Undisputed 01/23/2026 1078495759 CMS
Janssen Biotech, Inc. $141.64 08/09/2024 Food and Beverage Undisputed 01/23/2026 1078493627 CMS
Janssen Biotech, Inc. $38.47 08/09/2024 Food and Beverage Undisputed 01/23/2026 1078494617 CMS
Janssen Biotech, Inc. $75.86 08/11/2024 Food and Beverage Undisputed 01/23/2026 1078494451 CMS
Janssen Biotech, Inc. $71.14 08/11/2024 Food and Beverage Undisputed 01/23/2026 1078496459 CMS
Janssen Biotech, Inc. $9.42 09/24/2024 Food and Beverage Undisputed 01/23/2026 1078492573 CMS
Janssen Biotech, Inc. $36.62 09/24/2024 Food and Beverage Undisputed 01/23/2026 1078492738 CMS
Janssen Biotech, Inc. $140.17 12/07/2024 Food and Beverage Undisputed 01/23/2026 1078493032 CMS
Janssen Biotech, Inc. $57.67 12/08/2024 Food and Beverage Undisputed 01/23/2026 1078493164 CMS
Janssen Scientific Affairs, LLC $30,000.00 04/01/2024 Consulting Fee Disputed 01/23/2026 1078862505 CMS
Janssen Scientific Affairs, LLC $21,800.00 05/14/2024 Consulting Fee Undisputed 01/23/2026 1078862503 CMS
Legend Biotech USA Inc. $1,970.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1131693437 CMS
Legend Biotech USA Inc. $23.82 02/23/2024 Food and Beverage Undisputed 01/23/2026 1131693492 CMS
Legend Biotech USA Inc. $2,216.25 09/18/2024 Consulting Fee Undisputed 01/23/2026 1131691238 CMS
Legend Biotech USA Inc. $44.72 10/26/2024 Food and Beverage Undisputed 01/23/2026 1131691354 CMS
Legend Biotech USA Inc. $73.73 12/05/2024 Food and Beverage Undisputed 01/23/2026 1131691265 CMS
Legend Biotech USA Inc. $45.45 12/06/2024 Food and Beverage Undisputed 01/23/2026 1131693879 CMS
Legend Biotech USA Inc. $115.74 12/06/2024 Food and Beverage Undisputed 01/23/2026 1131694704 CMS
PFIZER INC. $50.52 09/25/2024 Food and Beverage Undisputed 01/23/2026 1131619701 CMS
SANOFI-AVENTIS U.S. LLC $68.21 02/23/2024 Food and Beverage Undisputed 01/23/2026 1139862784 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.